Raffa Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
Raffa Wealth Management's RDY Position: Q3 2026 in Review
Raffa Wealth Management increased its Dr. Reddy's Laboratories (RDY) stake by 25% in Q3 2026, buying an estimated $2.08K and bringing the position to 851 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #414.
Raffa Wealth Management first reported a position in RDY in Q1 2021 and has held it in 23 quarters since. 236 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- Raffa Wealth Management held 851 shares of Dr. Reddy's Laboratories worth $10.7K as of Q3 2026.
- Raffa Wealth Management bought 168 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $2.08K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #414 holding.
- Raffa Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2021 and has held it in 23 quarters since.
- 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.